Standards of Medical Care in Diabetes 2021
The Standards of Medical Care in Diabetes—2021 provides the latest in comprehensive, evidence-based recommendations for the diagnosis and treatment of children and adults with type 1, type 2, or gestational diabetes; strategies for the prevention or delay of type 2 diabetes; and therapeutic approaches that can reduce complications, mitigate cardiovascular and renal risk, and improve health outcomes.
This update presents:
Evolving evidence for diabetes treatment for people also managing chronic kidney disease and heart failure;
The use of technology for diabetes management and individualized care as well as recommendations for continuous glucose monitoring (CGM) for people with diabetes based on therapy;
Important information on addressing social determinants of health in diabetes;
Barriers to and critical times for diabetes self-management education and support (DSMES);
Vaccine-specific updates, including those related to COVID-19.
Today, the Standards of Care is available online and is published as a supplement to the January 2021 issue of Diabetes Care.
“The American Diabetes Association is committed to improving the lives of all those affected by diabetes through this publication of the most widely respected guidelines for health professionals,” said Dr. Robert Gabbay, Chief Scientific and Medical Officer at the American Diabetes Association.
Updates to the Standards of Care are established and revised by the ADA’s Professional Practice Committee (PPC). The committee is a multidisciplinary team of 16 leading U.S. experts in the field of diabetes care and includes physicians, diabetes care and education specialists, registered dietitians, and others with experience in adult and pediatric endocrinology, epidemiology, public health, cardiovascular risk management, microvascular complications, preconception and pregnancy care, weight management and diabetes prevention, and use of technology in diabetes management. Two designated representatives of the American College of Cardiology (ACC) reviewed and provided feedback on the “Cardiovascular Disease and Risk Management” section, and this section received endorsement from ACC. “As a world leader in diabetes care, the ADA is proud to set the standards!” said Boris Draznin, MD, PhD, Chair of the Professional Practice Committee.